Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
4
×
boston blog main
cancer diagnostics
medical device
san francisco blog main
san francisco top stories
boston top stories
cancer
clinical trials
deals
freenome
grail
liquid biopsy
raleigh-durham blog main
san francisco
thrive earlier detection
10x genomics
480 biomedical
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
aprea therapeutics
arimoclomol
arnold levine
arsenal medical
astellas pharma
baker brothers
becton dickinson
biotech ipos
bob langer
boehringer ingelheim
boston
cdg therapeutics
chronic rhinosinusitis
cirina
covid-19
daiichi sankyo
What
company
4
×
tests
4
×
developing
blood
cancer
ipo
public
treatment
adding
aims
announced
area
based
bay
biopsy
biotech
broader
buildout
close
deal
debut
decisions
detect
diagnostic
diagnostics
expand
files
firm
firms
fold
genomic
grail
help
intended
investors
join
late
life
liquid
lucence
Language
unset
Current search:
company
×
" national blog main "
×
tests
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow